Per a court order, HHS is required to restore this website to its version as of 12:00 AM on January 29, 2025. Information on this page may be modified and/or removed in the future subject to the terms of the court’s order and implemented consistent with applicable law. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from truth. The Trump Administration rejects gender ideology due to the harms and divisiveness it causes. This page does not reflect reality and therefore the Administration and this Department reject it.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Reduce infections of HPV types prevented by the vaccine in young adults — IID‑07 Data

National Status: Baseline only

  
Learn more about our data release schedule

Most Recent Data:
15.1 percent (2013-16)

National Target:
8.7 percent

Desired Direction:
Decrease desired

National Baseline:
15.1 percent of persons aged 20 to 34 years were positive for at least 1 HPV type prevented by the 9-valent vaccine in 2013-16

Disparities data are only available for some selections.

View CI in the chart by hovering over a data point.

View SE in the chart by hovering over a data point.

Confidence Interval (CI) not available Standard Error (SE) not available Confidence Interval (CI) and Standard Error (SE) are not available

Display data for:

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Total
15.1
CI 13.3 / 17.1
SE 0.950

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Sex, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Male
14.8
CI 12.1 / 18.1
SE 1.461
Female
15.4
CI 13.1 / 17.9
SE 1.165

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Race/Ethnicity, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
American Indian or Alaska Native only
DNC
Asian only
DNC
Native Hawaiian or Other Pacific Islander only
DNC
Black or African American only
DNC
White only
DNC
2 or more races
DNC
Hispanic or Latino
12.7
CI 9.6 / 16.8
SE 1.758
Not Hispanic or Latino
15.7
CI 13.8 / 17.8
SE 0.995
American Indian or Alaska Native only, not Hispanic or Latino
DNC
Asian only, not Hispanic or Latino
7.5
CI 4.4 / 12.4
SE 1.909
Native Hawaiian or Other Pacific Islander only, not Hispanic or Latino
DNC
Black or African American only, not Hispanic or Latino
27.7
CI 23.2 / 32.9
SE 2.377
White only, not Hispanic or Latino
14.1
CI 11.9 / 16.7
SE 1.175
2 or more races, not Hispanic or Latino
DNC

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Age group, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
20-24 years
14.8
CI 12.2 / 17.9
SE 1.412
25-29 years
16.2
CI 13.5 / 19.4
SE 1.433
30-34 years
14.2
CI 11.8 / 17.0
SE 1.262

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Educational attainment (25-34 years), 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Less than High school
16.4
CI 11.5 / 22.9
SE 2.776
High school (including GED or equivalent)
24.1
CI 18.6 / 30.7
SE 2.973
Some college or Associate degree
15.1
CI 12.6 / 17.9
SE 1.307
4-year college degree or more
10.6
CI 8.3 / 13.4
SE 1.252

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Family income (percent poverty threshold), 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
<100
15.9
CI 12.6 / 19.8
SE 1.753
100-199
14.4
CI 11.5 / 18.0
SE 1.608
200-399
15.3
CI 12.5 / 18.7
SE 1.510
400+
13.0
CI 9.3 / 17.9
SE 2.084

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Health insurance status, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Insured
13.7
CI 11.8 / 16.0
SE 1.028
Private
12.2
CI 10.0 / 14.7
SE 1.142
Public
20.1
CI 15.9 / 25.2
SE 2.289
Uninsured
18.9
CI 15.7 / 22.5
SE 1.655

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Geographic location, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Geographic location
DNA

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Marital status, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Married/​Cohabiting partner
11.5
CI 9.0 / 14.5
SE 1.327
Divorced, separated, widowed
24.6
CI 15.2 / 37.3
SE 5.461
Never married
18.3
CI 16.0 / 20.9
SE 1.187

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Country of birth, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
US
15.8
CI 13.9 / 18.0
SE 1.018
Outside US
11.6
CI 8.5 / 15.8
SE 1.782

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Veteran status (20-34 years), 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Veteran
DSU
Non-veteran
15.0
CI 13.0 / 17.2
SE 1.023

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Disability status (20-34 years), 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Disability status (20-34 years)
DNC

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Activity limitation (20-34 years), 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
With activity limitations
19.0
CI 12.5 / 27.8
SE 3.742
Without activity limitations
14.7
CI 12.8 / 16.9
SE 0.993

Young adults positive for at least 1 HPV type prevented by the 9-valent vaccine by Gender identity, 2013-16 ◊
(percent)
Decrease desired

Population 2013-16
Gender identity
DNC

Disparity